All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-34578363

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	34578363	A222V	S	S	COVID-19	R L	View
2	34578363	K77T	S	S	COVID-19	R L	View
3	34578363	L116F	ORF7a	ORF7a	COVID-19	R L	View
4	34578363	A1306S	ORF1ab	ORF1ab	COVID-19	R L	View
5	34578363	A3209V	ORF1ab	ORF1ab	COVID-19	R L	View
6	34578363	A6319V	ORF1ab	ORF1ab	COVID-19	R L	View
7	34578363	D2980N	ORF1ab	ORF1ab	COVID-19	R L	View
8	34578363	F3138S	ORF1ab	ORF1ab	COVID-19	R L	View
9	34578363	G5063S	ORF1ab	ORF1ab	COVID-19	R L	View
10	34578363	P2046L	ORF1ab	ORF1ab	COVID-19	R L	View
11	34578363	P2287S	ORF1ab	ORF1ab	COVID-19	R L	View
12	34578363	P309L	ORF1ab	ORF1ab	COVID-19	R L	View
13	34578363	P5401L	ORF1ab	ORF1ab	COVID-19	R L	View
14	34578363	T3255I	ORF1ab	ORF1ab	COVID-19	R L	View
15	34578363	T3446A	ORF1ab	ORF1ab	COVID-19	R L	View
16	34578363	T3750I	ORF1ab	ORF1ab	COVID-19	R L	View
17	34578363	V2930L	ORF1ab	ORF1ab	COVID-19	R L	View
18	34578363	V3718A	ORF1ab	ORF1ab	COVID-19	R L	View
19	34578363	G215C	N	N	COVID-19	R L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.